Tech Center 1600 • Art Units: 1636 1645 1651
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18452127 | HIGH-THROUGHPUT METHODS FOR ANALYZING AND AFFINITY-MATURING AN ANTIGEN-BINDING MOLECULE | Non-Final OA | 10x Genomics, Inc. |
| 18249016 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT | Non-Final OA | UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION |
| 18254324 | MEDIATORS OF GENE SILENCING | Non-Final OA | CANCER RESEARCH TECHNOLOGY LIMITED |
| 18457605 | GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER | Non-Final OA | Therapeutic Solutions International, Inc. |
| 17603347 | COMPOSITIONS AND METHODS FOR THE STABILIZATION OF MICRO-RNA | Final Rejection | GENFIT |
| 18495687 | SIRNAS AGAINST KRAS AND RAF1 | Non-Final OA | SIRNAOMICS, INC. |
| 17951842 | METHODS FOR PREPARING NANOPARTICLE COMPOSITIONS CONTAINING HISTIDINE-LYSINE COPOLYMERS | Non-Final OA | Sirnaomics, Inc. |
| 18269479 | APTAMERS AND USE OF THE APTAMERS IN THE DIAGNOSIS AND TREATMENT OF A SARS-COV-2 INFECTION | Non-Final OA | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
| 18184721 | VIRULENCE FACTOR FSPL GENE FROM SUGARCANE POKKAH BOENG DISEASE AND USE THEREOF | Non-Final OA | GUANGXI UNIVERSITY |
| 18266592 | GENE TRANSCRIPTION FRAMEWORK, VECTOR SYSTEM, GENOME SEQUENCE EDITING METHOD AND APPLICATION | Non-Final OA | Shuanghong PENG |
| 15734918 | LABELING OF DNA | Non-Final OA | Bionano Genomics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy